Dyne Therapeutics, Inc. (DYN) — Biotechnology. Numbers-first dossier: valuation, distress risk, calibrated signal.

How we compute this

Qtick
Sign in
Bid — × — AskUpdated Nov 10, 2026 · 1:17 PM ETVol 1.12M · 3-mo avg 2.84M

Dyne Therapeutics, Inc. (DYN)

DYNDyne Therapeutics, Inc.loading…
loading…
QTick signal
-10net
0 bull / 5 bear factors · moderate
Bull 1 pts·Bear 11 pts30d
loading…
Market context—Sector read · not on file—Balance sheet · not on file—Inflation-report days · not on file—Sharp-drop check · not on file
—
not on file
—
not on file
—
not on file
—
not on file
not on file
Trading volume49% above normal1.49× its 20-day average
Past year's range$14.00 – $27.31lowest to highest price
From its peaknot on file
Momentum (RSI)not on file

Last session traded in line with its own normal. Over the last 20 sessions, 37% of the volume traded on days the stock closed lower.

Entry strategy · 10 triggers

0 of 6 evaluable
RSI 14Static
—
not on file
vs 50-day
●
—
not on file
Bollinger
●
—
not on file
VWAP 20
●
—
not on file
Entry level
●
—
not on file
Put wall
●
—
not on file
MACDStatic
—
not on file
RVolStatic
1.49×
in line with its own normal
Short int.Static
—
not on file
ATRStatic
—
not on file
A checklist, not odds on a return: 4 of 6 usable price conditions have to line up. RSI, the 50-day average and the Bollinger band move with the price you set; the 20-day average traded price, the entry level and the busiest put strike stay fixed. MACD, RVol, Short int. and ATR are context only — they never count toward the total.
See the full case→
Next earnings
—
not on file
Next dividend
—
dividend data not on file